AUROPHARMA Intraday Analysis...

AUROPHARMA Share Price

Open 842.00 Change Price %
High 849.00 1 Day -2.45 -0.29
Low 835.00 1 Week 33.85 4.21
Close 838.70 1 Month 48.75 6.17
Volume 1622232 1 Year 96.75 13.04
52 Week High 891.50
52 Week Low 582.00
AUROPHARMA Important Levels
Resistance 2 851.68
Resistance 1 846.33
Pivot 840.90
Support 1 831.07
Support 2 825.72
NSE INDIA Most Active Stocks
GTLINFRA 4.45 9.88%
MARKSANS 52.75 10.59%
RCOM 47.45 -0.84%
IFCI 28.80 -5.42%
JPASSOCIAT 11.10 -2.63%
IBREALEST 88.40 0.45%
AXISBANK 547.40 -1.80%
ADLABS 112.25 12.25%
ICICIBANK 262.55 -3.21%
IDFCBANK 73.15 1.88%
More..
NSE INDIA Top Gainers Stocks
RAJRAYON 0.30 20.00%
MRO-TEK 75.70 19.97%
BPL 91.10 19.95%
BPL 91.10 19.95%
BPL 91.10 19.95%
SAKUMA 69.20 19.93%
HINDDORROL 12.95 19.91%
KILITCH 40.40 19.88%
BIGBLOC 53.50 19.69%
VIVIDHA 2.55 18.60%
More..
NSE INDIA Top Losers Stocks
FARMAXIND 0.10 -33.33%
KSERASERA 0.15 -25.00%
PARASPETRO 0.20 -20.00%
FCSSOFT 0.25 -16.67%
BHARATIDIL 20.55 -14.73%
ISMTLTD 10.25 -9.29%
LSIL 1.50 -9.09%
GTOFFSHORE 32.20 -8.78%
KAUSHALYA 6.50 -8.45%
PRESTIGE 200.10 -7.87%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 5
As on 26th Sep 2016 AUROPHARMA Share Price closed @ 838.70 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 777.30 & Strong Buy for SHORT-TERM with Stoploss of 780.17 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for September
1st Target up-side 833.25
2nd Target up-side 862.97
3rd Target up-side 892.69
1st Target down-side 748.45
2nd Target down-side 718.73
3rd Target down-side 689.01
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 64.23 Sideways
MFI (14) MFI is Above 80 Over Bought
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is -25.06 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 785.77
10 Day Avg Volume Traded -31.04 % Less then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.